Glycine-site antagonists and stroke (Q34119544)

31 July 2017

Glycine-site antagonists and stroke (English)

1 reference

31 July 2017

Tranquillini ME

1

1 reference

PubMed ID

11139828

31 July 2017

Reggiani A

series ordinal

2

1 reference

PubMed ID

11139828

31 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

1 reference

31 July 2017

8

1 reference

31 July 2017

11

1 reference

31 July 2017

1837-1848

1 reference

Cloned glutamate receptors

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Alternatively spliced isoforms of the NMDARI receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

The glycine site of the NMDA receptor--five years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

[3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Stroke risk factors and stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Excitatory Amino Acid Transmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

N-methyl-D-aspartate antagonists for stroke and head trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Autoradiographic assessment of the effects of N-methyl-d-aspartate (NMDA) receptor antagonists in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as selective glycine antagonist with in vivo activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Novel glycineB antagonists show neuroprotective activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

Glycine potentiates the NMDA response in cultured mouse brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1837

10.1517/13543784.8.11.1837

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11139828